Results 111 to 120 of about 9,772 (228)

Triptane [PDF]

, 2020
openaire   +1 more source

Evolution of use and overuse of triptans in Austria - What has changed in the last 15 years? [PDF]

J Headache Pain
Kaltseis K, Maier S, Zebenholzer K, Eller MT, Gufler L, Frank F, Broessner G.   +6 more
europepmc   +1 more source

Integrating gepants into clinical practice for the acute treatment of migraine. [PDF]

Headache
Lipton RB, Dodick DW, Davis L, Nahas SJ, Goadsby PJ.   +4 more
europepmc   +1 more source

Triptans for Migraine: Balancing Potential Vascular Risk With Meaningful Benefit. [PDF]

J Am Heart Assoc
Hougaard A.
europepmc   +1 more source

Oral Triptan Therapy [PDF]

Headache: The Journal of Head and Face Pain, 2006
openaire   +2 more sources

Sex-specific management of migraine a systematic review and consensus statement from the European Headache Federation (EHF). [PDF]

J Headache Pain
Braca S, Casillo F, Moreira S, Ekizoglu E, Bjork MH, Szewczyk AK, Van Dycke A, Uluduz D, Coppola G, Deligianni C, Lampl C, Tronvik E, Amin FM, Versijpt J, Ryliškienė K, Rio MSD, Holland PR, Terwindt G, Reuter U, MaassenVanDenBrink A, Gil-Gouveia R.   +20 more
europepmc   +1 more source

Innovative treatments for migraine: a new era. [PDF]

Ther Adv Neurol Disord
Pistoia F.
europepmc   +1 more source

Migraine and the Excessive Dispensation of Triptans: A Real-World Evidence Study of Colombian Patients. [PDF]

Rev Neurol
Valladales-Restrepo LF, Díaz-Arteaga C, Navarrete-Santa LF, Santander-Pai MJ, Zapata-Orozco JM, Villa-Arroyave G, Machado-Alba JE.   +6 more
europepmc   +1 more source

Theoretical analysis of headache recurrence in patients administered triptans for migraine based on receptor occupancy [PDF]

, 2015
Kentaro Tokuoka, Masayuki Watanabe, Mioko Toyabe, Risa Takayanagi, Yasuhiko Yamada, Yasuhisa Kitagawa   +5 more
core   +1 more source

Triptans in prevention of menstrual migraine: a systematic review with meta-analysis [PDF]

, 2013

core   +1 more source